{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T23:27:00Z","timestamp":1792106820403,"version":"4.4.0"},"reference-count":81,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Rheumatology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.berh.2005.06.008","type":"journal-article","created":{"date-parts":[[2006,12,1]],"date-time":"2006-12-01T21:56:07Z","timestamp":1165010167000},"page":"1065-1079","source":"Crossref","is-referenced-by-count":52,"title":["Bone loss in inflammatory arthritis: mechanisms and therapeutic approaches with bisphosphonates"],"prefix":"10.1016","volume":"19","author":[{"given":"Evan","family":"Romas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.berh.2005.06.008_bib1","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/ar67","article-title":"Mechanisms of bone loss in inflammatory arthritis: diagnosis and therapeutic implications","volume":"2","author":"Goldring","year":"2000","journal-title":"Arthritis Research"},{"key":"10.1016\/j.berh.2005.06.008_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0950-351X(97)80473-9","article-title":"Bone biology","volume":"11","author":"Ng","year":"1997","journal-title":"Baillieres Clinical Endocrinology and Metabolism"},{"key":"10.1016\/j.berh.2005.06.008_bib3","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1136\/ard.62.7.617","article-title":"Radiographic joint destruction in postmenopausal rheumatoid arthritis is strongly associated with generalised osteoporosis","volume":"62","author":"Forsblad D'Elia","year":"2003","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2005.06.008_bib4","first-page":"2541","article-title":"The skeleton in rheumatoid arthritis: common mechanisms for bone erosion and osteoporosis?","volume":"27","author":"Sambrook","year":"2000","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2005.06.008_bib5","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1080\/08916930400011965","article-title":"Anti-cyclic citrullinated peptide antibodies are highly associated with severe bone lesions in rheumatoid arthritis","volume":"37","author":"Bongi","year":"2004","journal-title":"Autoimmunity"},{"key":"10.1016\/j.berh.2005.06.008_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis and Rheumatism"},{"issue":"supplement 57","key":"10.1016\/j.berh.2005.06.008_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3109\/03009748509104317","article-title":"Prognostic factors and diagnostic criteria in early rheumatoid arthritis","volume":"14","author":"Kaarela","year":"1985","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"supplement 2","key":"10.1016\/j.berh.2005.06.008_bib8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/rheumatology\/XXXIV.suppl_4.74","article-title":"Joint erosions and patients with early rheumatoid arthritis","volume":"34","author":"van der Heijde","year":"1995","journal-title":"British Journal of Rheumatology"},{"key":"10.1016\/j.berh.2005.06.008_bib9","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/ard.57.6.350","article-title":"Magnetic resonance imaging of the wrist in early rheumatoid arthritis reveals a high prevalence of erosion at four months after symptom onset","volume":"57","author":"McQueen","year":"1998","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2005.06.008_bib10","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1002\/art.11076","article-title":"New radiographic bone erosions in the wrists of patients with rheumatoid arthritis are detectable with magnetic resonance imaging a median of two years earlier","volume":"48","author":"\u00d8stergaard","year":"2003","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib11","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/art.11162","article-title":"Bone edema scored on magnetic resonance imaging scans of the dominant carpus at presentation predicts radiographic joint damage of the hands and feet six years later in patients with rheumatoid arthritis","volume":"48","author":"McQueen","year":"2003","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib12","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1002\/1529-0131(199908)42:8<1706::AID-ANR20>3.0.CO;2-Z","article-title":"The relationship between synovitis and bone changes in early untreated rheumatoid arthritis. A controlled magnetic resonance imaging study","volume":"42","author":"McGonagle","year":"1999","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1093\/rheumatology\/38.4.329","article-title":"A preliminary study of ultrasound aspiration of bone erosion in early rheumatoid arthritis","volume":"38","author":"Gibbon","year":"1999","journal-title":"Rheumatology"},{"key":"10.1016\/j.berh.2005.06.008_bib14","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","article-title":"Osteoclast differentiation and activation","volume":"423","author":"Boyle","year":"2003","journal-title":"Nature"},{"key":"10.1016\/j.berh.2005.06.008_bib15","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1136\/ard.61.11.1007","article-title":"Assessing periarticular bone mineral density in patients with early psoriatic arthritis or rheumatoid arthritis","volume":"61","author":"Harrison","year":"2002","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2005.06.008_bib16","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0953-6205(02)00129-2","article-title":"Peripheral bone density in patients with rheumatoid arthritis and factors which influence it","volume":"13","author":"Kelly","year":"2002","journal-title":"European Journal of Internal Medicine"},{"key":"10.1016\/j.berh.2005.06.008_bib17","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/art.1780280105","article-title":"Quantitative histologic studies on the pathogenesis of periarticular osteoporosis in rheumatoid arthritis","volume":"28","author":"Shimizu","year":"1985","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1136\/ard.51.6.826","article-title":"Bone mass in patients with rheumatoid arthritis","volume":"51","author":"Laan","year":"1992","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2005.06.008_bib19","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10067-002-8274-7","article-title":"Cross-sectional and longitudinal study of osteoporosis in patients with rheumatoid arthritis","volume":"21","author":"Shibuya","year":"2002","journal-title":"Clinical Rheumatology"},{"key":"10.1016\/j.berh.2005.06.008_bib20","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1002\/art.1780300701","article-title":"Determinants of axial bone loss in rheumatoid arthritis","volume":"30","author":"Sambrook","year":"1987","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib21","first-page":"2582","article-title":"A multicenter cross-sectional study on bone mineral density in rheumatoid arthritis","volume":"27","author":"Sinigaglia","year":"2000","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2005.06.008_bib22","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/1529-0131(200003)43:3<522::AID-ANR7>3.0.CO;2-Y","article-title":"Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo County Rheumatoid Arthritis register","volume":"43","author":"Haugeberg","year":"2000","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib23","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1093\/rheumatology\/40.12.1375","article-title":"Prevalence of vertebral deformities and symptomatic vertebral fractures in corticosteroid treated patients with rheumatoid arthritis","volume":"40","author":"de Nijs","year":"2001","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2005.06.008_bib24","first-page":"1282","article-title":"Osteoclastic activation is the principal mechanism leading to secondary osteoporosis in rheumatoid arthritis","volume":"25","author":"Gough","year":"1998","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2005.06.008_bib25","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(94)91049-9","article-title":"Generalised bone loss in patients with early rheumatoid arthritis occurs early and relates to disease activity","volume":"344","author":"Gough","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.berh.2005.06.008_bib26","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1002\/art.1780380705","article-title":"Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Effects of corticosteroids and hormone replacement therapy","volume":"38","author":"Hall","year":"1995","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00223-002-1024-7","article-title":"Urinary cross-linked N-telopeptides of type I collagen levels in patients with rheumatoid arthritis","volume":"72","author":"Iwamoto","year":"2003","journal-title":"Calcified Tissue International"},{"key":"10.1016\/j.berh.2005.06.008_bib28","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1136\/ard.53.1.14","article-title":"Excretion of pyridinium crosslinks correlates with disease activity and appendicular bone loss in early rheumatoid arthritis","volume":"53","author":"Gough","year":"1994","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2005.06.008_bib29","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1002\/art.1780270902","article-title":"Chondroclasts and osteoclasts at subchondral sites of erosion in the rheumatoid joint","volume":"27","author":"Bromley","year":"1984","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib30","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1136\/ard.44.10.676","article-title":"Bidirectional erosion of cartilage in the rheumatoid knee joint","volume":"44","author":"Bromley","year":"1985","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2005.06.008_bib31","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1002\/art.10747","article-title":"Elucidation of the relationship between synovitis and bone damage: a randomized magnetic resonance imaging study of individual joints in patients with early rheumatoid arthritis","volume":"48","author":"Conaghan","year":"2003","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib32","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/er.21.2.115","article-title":"Birth and death of bone cells: basic regulatory mechanisms and implications for the pathogenesis and treatment of osteoporosis","volume":"21","author":"Manolagas","year":"2000","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.berh.2005.06.008_bib33","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S8756-3282(01)00682-2","article-title":"Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis","volume":"30","author":"Romas","year":"2002","journal-title":"Bone"},{"key":"10.1016\/j.berh.2005.06.008_bib34","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","article-title":"Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor","volume":"43","author":"Gravallese","year":"2000","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib35","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/1529-0131(200002)43:2<259::AID-ANR4>3.0.CO;2-W","article-title":"Involvement of receptor activator of nuclear factor kappaB ligand\/ osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis","volume":"43","author":"Takayanagi","year":"2000","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib36","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1006\/bbrc.1999.1623","article-title":"Activated T lymphocytes support osteoclast formation in vitro","volume":"265","author":"Horwood","year":"1999","journal-title":"Biochemical and Biophysical Research Communications"},{"key":"10.1016\/j.berh.2005.06.008_bib37","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1002\/1529-0131(200004)43:4<821::AID-ANR12>3.0.CO;2-T","article-title":"Expression of osteoclast differentiation factor at sites of bone erosion in collagen-induced arthritis","volume":"43","author":"Romas","year":"2000","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib38","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/S0002-9440(10)64417-3","article-title":"Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis","volume":"161","author":"Romas","year":"2002","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.berh.2005.06.008_bib39","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1002\/art.10607","article-title":"Increase in expression of receptor activator of nuclear factor kappaB at sites of bone erosion correlates with progression of inflammation in evolving collagen-induced arthritis","volume":"46","author":"Lubberts","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib40","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1172\/JCI200316069","article-title":"Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis","volume":"111","author":"Ritchlin","year":"2003","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2005.06.008_bib41","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/art.11419","article-title":"Systemic TNF-alpha mediates an increase in peripheral CD11bhi osteoclast precursors in TNF-alpha transgenic mice","volume":"50","author":"Li","year":"2003","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib42","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/46303","article-title":"Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand","volume":"402","author":"Kong","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.berh.2005.06.008_bib43","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0002-9440(10)63016-7","article-title":"TRANCE\/RANKL knockout mice are protected from bone erosion in a serum transfer model of arthritis","volume":"159","author":"Pettit","year":"2001","journal-title":"The American Journal of Pathology"},{"key":"10.1016\/j.berh.2005.06.008_bib44","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1172\/JCI0215582","article-title":"Osteoclasts are essential for TNF-alpha-mediated joint destruction","volume":"110","author":"Redlich","year":"2002","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2005.06.008_bib45","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/art.10097","article-title":"Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin","volume":"46","author":"Redlich","year":"2002","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib46","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1359\/JBMR.0301233","article-title":"RANK signaling independent and dependent stages of osteoclastogenesis in TNF-induced erosive arthritis","volume":"19","author":"Li","year":"2003","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2005.06.008_bib47","first-page":"480","article-title":"Cytokine production in the rhumatoid joint: Implications for treatment","volume":"49","author":"Feldman","year":"1990","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2005.06.008_bib48","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1615\/CritRevEukarGeneExpr.v8.i2.10","article-title":"Interleukins in the control of osteoclast differentiation","volume":"8","author":"Martin","year":"1998","journal-title":"Critical Reviews in Eukaryotic Gene Expression"},{"key":"10.1016\/j.berh.2005.06.008_bib49","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1172\/JCI11176","article-title":"TNF-alpha induces osteoclastogenesis by direct stimulation of macrophages exposed to permissive levels of RANK ligand","volume":"106","author":"Lam","year":"2000","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2005.06.008_bib50","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1172\/JCI11066","article-title":"Estrogen deficiency induces bone loss by enhancing T-cell production of TNF-alpha","volume":"106","author":"Cenci","year":"2000","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2005.06.008_bib51","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1359\/jbmr.2000.15.7.1321","article-title":"Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand\/osteoprotegerin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency","volume":"15","author":"Kanematsu","year":"2000","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2005.06.008_bib52","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1172\/JCI200523394","article-title":"IL-1 mediates TNF-induced osteoclastogenesis","volume":"115","author":"Wei","year":"2005","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2005.06.008_bib53","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1172\/JCI20742","article-title":"TNF-alpha is crucial for the development of autoimmune arthritis in IL-1 receptor antagonist-deficient mice","volume":"114","author":"Horai","year":"2004","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.berh.2005.06.008_bib54","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1359\/JBMR.040305","article-title":"A single-dose placebo-controlled study of AMG 162, a fully human monoclonalantibody to RANKL, in postmenopausal women","volume":"19","author":"Bekker","year":"2004","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2005.06.008_bib55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","article-title":"Bisphosphonates: from the laboratory to the clinic and back again","volume":"25","author":"Russell","year":"1999","journal-title":"Bone"},{"issue":"supplement 2","key":"10.1016\/j.berh.2005.06.008_bib56","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/jbmr.5650140212","article-title":"The pharmacology of bisphosphonates and new insights into their mechanisms of action","volume":"14","author":"Russell","year":"1999","journal-title":"Journal of Bone and Mineral Research"},{"key":"10.1016\/j.berh.2005.06.008_bib57","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.bone.2003.07.007","article-title":"Differentiating the mechanisms of antiresorptive action of nitrogen containing bisphosphonates","volume":"33","author":"Van Beek","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.berh.2005.06.008_bib58","doi-asserted-by":"crossref","first-page":"3721","DOI":"10.1021\/jm020819i","article-title":"Highly potent geminal bisphosphonates. From pamidronate disodium (aredia) to zoledronic acid (zometa)","volume":"45","author":"Widler","year":"2002","journal-title":"Journal of Medicinal Chemistry"},{"key":"10.1016\/j.berh.2005.06.008_bib59","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1002\/art.1780220405","article-title":"Comparative antiinflammatory and bone protective effects of two diphosphonates in adjuvant arthritis","volume":"22","author":"Flora","year":"1979","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib60","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1002\/art.10987","article-title":"Effect of minodronic acid (ONO-5920) on bone mineral density and arthritis in adult rats with collagen-induced arthritis","volume":"48","author":"Yamane","year":"2003","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib61","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s000110050093","article-title":"A comparison of clodronate and indomethacin in the treatment of adjuvant arthritis","volume":"46","author":"Osterman","year":"1997","journal-title":"Inflammation Research"},{"key":"10.1016\/j.berh.2005.06.008_bib62","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/BF01782979","article-title":"Effect of clodronate on established collagen-induced arthritis in rats","volume":"44","author":"Osterman","year":"1995","journal-title":"Inflammation Research"},{"key":"10.1016\/j.berh.2005.06.008_bib63","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00579699","article-title":"Effect of clodronate on established adjuvant arthritis","volume":"14","author":"Osterman","year":"1994","journal-title":"Rheumatology International"},{"key":"10.1016\/j.berh.2005.06.008_bib64","first-page":"239","article-title":"NE-58095: a diphosphonate which prevents bone erosion and preserves joint architecture in experimental arthritis","volume":"11","author":"Francis","year":"1989","journal-title":"International Journal of Tissue Reactions"},{"key":"10.1016\/j.berh.2005.06.008_bib65","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1002\/art.1780381211","article-title":"Long-term amelioration of rat adjuvant arthritis following systemic elimination of macrophages by clodronate-containing liposomes","volume":"38","author":"Kinne","year":"1995","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib66","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3109\/03009749509100907","article-title":"Treatment of rat arthritides with clodronate-containing liposomes","volume":"101","author":"Kinne","year":"1995","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.berh.2005.06.008_bib67","first-page":"1280","article-title":"Antiinflammatory and chondroprotective effects of the aminobisphosphonates incadronate (YM175) in adjuvant induced arthritis","volume":"30","author":"Matsuo","year":"2003","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2005.06.008_bib68","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1093\/rheumatology\/38.9.818","article-title":"Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis","volume":"38","author":"Richards","year":"1999","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/j.berh.2005.06.008_bib69","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1002\/art.20382","article-title":"Targeting osteoclasts with zoledronic acid prevents bone destruction in collagen-induced arthritis","volume":"50","author":"Sims","year":"2004","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib70","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJMoa011807","article-title":"Intravenous zoledronic acid in postmenopausal women with low bone mineral density","volume":"346","author":"Reid","year":"2002","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.berh.2005.06.008_bib71","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1002\/art.20384","article-title":"Zoledronic acid protects against local and systemic bone loss in tumor necrosis factor-mediated arthritis","volume":"50","author":"Herrak","year":"2004","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib72","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1136\/ard.48.5.396","article-title":"Clinical, biochemical, and radiographic effects of aminohydroxypropylidene bisphosphonate treatment in rheumatoid arthritis","volume":"48","author":"Ralston","year":"1989","journal-title":"Annals of the Rheumatic Diseases"},{"key":"10.1016\/j.berh.2005.06.008_bib73","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1007\/PL00000240","article-title":"Clinical and biochemical response to single infusion of clodronate in active rheumatoid arthritis - a double blind placebo controlled study","volume":"50","author":"Valleala","year":"2001","journal-title":"Inflammation Research"},{"key":"10.1016\/j.berh.2005.06.008_bib74","first-page":"468","article-title":"Two year randomized controlled trial of etidronate in rheumatoid arthritis: changes in serum aminoterminal telopeptides correlate with radiographic progression of disease","volume":"30","author":"Valleala","year":"2003","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2005.06.008_bib75","first-page":"2016","article-title":"Clinical and biochemical response to single infusion of pamidronate in patients with active rheumatoid arthritis: a double blind placebo controlled study","volume":"21","author":"Eggelmeijer","year":"1994","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2005.06.008_bib76","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3109\/03009749409103063","article-title":"Double blind radiological assessment of continuous oral pamidronic acid in patients with rheumatoid arthritis","volume":"23","author":"Maccagno","year":"1994","journal-title":"Scandinavian Journal of Rheumatology"},{"key":"10.1016\/j.berh.2005.06.008_bib77","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/art.1780390307","article-title":"Increased bone mass with pamidronate treatment in rheumatoid arthritis. Results of a three-year randomized, double-blind trial","volume":"39","author":"Eggelmeijer","year":"1996","journal-title":"Arthritis and Rheumatism"},{"key":"10.1016\/j.berh.2005.06.008_bib78","first-page":"2080","article-title":"Effects of high dose intravenous pamidronate on disease activity and bone metabolism in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial","volume":"30","author":"Lodder","year":"2003","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2005.06.008_bib79","first-page":"2318","article-title":"Evaluation of bone turnover and osteoclastic cytokines in early rheumatoid arthritis treated with alendronate","volume":"26","author":"Cantatore","year":"1999","journal-title":"The Journal of Rheumatology"},{"key":"10.1016\/j.berh.2005.06.008_bib80","series-title":"Presented at: EULAR 2004; Berlin, Germany; June 9\u201312","article-title":"First Evidence of Structural Benefit from a Bisphosphonate, Zoledronic Acid in Rheumatoid Arthritis","author":"Jarrett","year":"2004"},{"key":"10.1016\/j.berh.2005.06.008_bib81","series-title":"Presented at: EULAR 2004; Berlin, Germany; June 9\u201312","article-title":"Profound Effect of Zoledronic Acid on Bone Mineral Density in Rheumatoid Arthritis","author":"Jarrett","year":"2004"}],"container-title":["Best Practice &amp; Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694205000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694205000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,10]],"date-time":"2019-01-10T23:55:01Z","timestamp":1547164501000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694205000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":81,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S1521694205000793"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2005.06.008","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}